Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

436
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
436
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Glaucoma: Overview01:25

Glaucoma: Overview

507
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
507

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

[TES-GPS and VIRON: clinical trials on electrical stimulation for glaucomatous optic neuropathy].

Die Ophthalmologie·2026
Same author

Predicting bleb revision after XEN gel stent surgery in a real-world open-angle glaucoma cohort.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Optimizing topical glaucoma treatment outcomes: When less is better. A review on the clinical benefits of reducing treatment burden in glaucoma management.

European journal of ophthalmology·2026
Same author

Factors influencing the long-term-success of the XEN gel stent.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026
Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026
Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026
Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026
Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026
Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026
查看所有相关文章

相关实验视频

Updated: Jun 5, 2025

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
04:06

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Published on: September 13, 2024

1.7K

最少侵入性玻璃眼外科手术

Bogomil Voykov1, Verena Prokosch, Jan Lübke

  • 1University Eye Hospital, University Clinic Tuebingen; Department of Ophthalmology, University Hospital Cologne; Eye Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Deutsches Arzteblatt international
|December 13, 2024
PubMed
概括
此摘要是机器生成的。

微创性玻璃眼外科手术,包括iStent注射和Hydrus Microshunt,有效降低眼内压力,减少药物需求. 需要进一步的试验来证实其他新型玻璃眼手术的疗效.

更多相关视频

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.1K

相关实验视频

Last Updated: Jun 5, 2025

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
04:06

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Published on: September 13, 2024

1.7K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.1K

科学领域:

  • 眼科医生 眼科 眼科
  • 手术创新 在外科创新.
  • 视光眼的管理 视光眼的管理

背景情况:

  • 玻璃眼会影响到1.4%的35-74岁的德国人,是导致失明的主要原因.
  • 降低眼内压力是唯一一种基于证据的治疗方法.
  • 最少侵入性玻璃眼手术为传统方法提供了更安全的替代方案.

研究的目的:

  • 审查目前对最小侵入性玻璃眼外科手术程序的证据.
  • 评估新的眼内压力降低技术的有效性和安全性.
  • 为了比较不同青光眼手术干预的结果.

主要方法:

  • 对PubMed出版物的选择性审查.
  • 包括随机对照试验和元分析.
  • 对特定的最小侵入性玻璃眼手术研究的分析.

主要成果:

  • 带切除术是标准的,但有3-15%的并发症率.
  • 使用支架进行的最小侵入性玻璃眼外科手术显示,对轻度/中度玻璃眼的安全性更好.
  • 注射iStent和Hydrus Microshunt显示显著降低眼内压力,并减缓视野缺陷.

结论:

  • 注射iStent和Hydrus Microshunt在降低眼内压力和减少对眼滴的依赖方面是有效的.
  • 高质量的受控试验是必要的,以验证其他最小侵入性玻璃眼手术.
  • 最少侵入性玻璃眼外科手术是一种有希望的,更安全的方法来治疗玻璃眼.